对比增强锥形束乳腺CT特征与乳腺癌预后分期的相关性
本研究分析168例活检证实的乳腺癌患者,训练集115例于2019年8月至12月使用v.1.5 CE-CBBCT扫描,测试集53例于2012年5月至2014年8月使用v.1.0 CE-CBBCT扫描,按AJCC第八版预后分期重新分期。结果显示肿瘤与乳腺体积比增大、环形强化模式和穿支血管存在是预后分期II/III的显著预测因素,训练集AUC为0.967,测试集AUC为0.896。
要点
- CE-CBBCT上肿瘤与乳腺体积比增大、环形强化和穿支血管存在提示预后分期II/III。
- 训练集区分预后分期I与II/III的AUC为0.967,测试集为0.896。
- 预后分期II与III间在测试集无显著差异(P>0.05)。
核心结论
- CE-CBBCT影像生物标志物可能为术前区分预后分期提供大量解剖和放射生物学信息。
研究设计与样本
- 研究论文,共168例活检证实的乳腺癌患者,训练集115例使用v.1.5 CE-CBBCT(2019年8月至12月),测试集53例使用v.1.0 CE-CBBCT(2012年5月至2014年8月),按AJCC第八版预后分期系统重新分期,采用逻辑回归分析预测因素,以AUC评估预测性能,Hosmer-Lemeshow检验评估模型拟合优度。
关键影像表现/征象
- 肿瘤与乳腺体积比增大是预后分期II/III的显著预测因素(p < 0.05)。
- 环形强化模式是预后分期II/III的显著预测因素(p < 0.05)。
- 穿支血管存在是预后分期II/III的显著预测因素(p < 0.05)。
诊断标准与关键数值
- 训练集区分预后分期I与II/III的AUC为0.967(95%CI 0.938-0.996;p < 0.001)。
- 测试集区分预后分期I与II/III的AUC为0.896(95%CI 0.809-0.983;p = 0.001)。
- 训练集预后分期II与III间,肿瘤体积OR=1.817(p = 0.019),钙化OR=4.600(p = 0.040),AUC为0.790(95%CI 0.636-0.944,p = 0.001)。
- 测试集预后分期II与III间无显著差异(P>0.05)。
局限性
- 测试集预后分期II与III间无显著差异(P>0.05)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate whether contrast-enhanced cone-beam breast CT (CE-CBBCT) features can risk-stratify prognostic stage in breast cancer.
METHODS: Overall, 168 biopsy-proven breast cancer patients were analysed: 115 patients in the training set underwent scanning using v. 1.5 CE-CBBCT between August 2019 and December 2019, whereas 53 patients in the test set underwent scanning using v. 1.0 CE-CBBCT between May 2012 and August 2014. All patients were restaged according to the American Joint Committee on Cancer eighth edition prognostic staging system. Following the combination of CE-CBBCT imaging parameters and clinicopathological factors, predictors that were correlated with stratification of prognostic stage via logistic regression were analysed. Predictive performance was assessed according to the area under the receiver operating characteristic curve (AUC). Goodness-of-fit of the models was assessed using the Hosmer-Lemeshow test.
RESULTS: As regards differentiation between prognostic stage (PS) I and II/III, increased tumour-to-breast volume ratio (TBR), rim enhancement pattern, and the presence of penetrating vessels were significant predictors for PS II/III disease (p < 0.05). The AUCs in the training and test sets were 0.967 [95% confidence interval (CI) 0.938-0.996; p < 0.001] and 0.896 (95% CI, 0.809-0.983; p = 0.001), respectively. Two features were selected in the training set of PS II vs III, including tumour volume [odds ratio (OR)=1.817, p = 0.019] and calcification (OR = 4.600, p = 0.040), achieving an AUC of 0.790 (95% CI, 0.636-0.944, p = 0.001). However, there was no significant difference in the test set of PS II vs III (P>0.05).
CONCLUSION: CE-CBBCT imaging biomarkers may provide a large amount of anatomical and radiobiological information for the pre-operative distinction of prognostic stage.
ADVANCES IN KNOWLEDGE: CE-CBBCT features have distinctive promise for stratification of prognostic stage in breast cancer.
引用
- Ma, Li, Chen, et al. Correlation between contrast-enhanced cone-beam breast computed tomography features and prognostic staging in breast cancer. Br J Radiol. 2022. PMID: 34930038. doi:10.1259/bjr.20210466
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。